June 21, 2015 | Teva Pharmaceutical Industries and Microchips Biotech announced a partnership to explore integrating Microchip’s implantable drug delivery device into Teva’s products. The goal of such a partnership would be to improve the outcomes for patients that engage in chronic therapy. Microchip’s innovative technology can administer drugs over a period of months to years, releasing the drugs at pre-determined times.
Related posts
Israel's Top Hospital Unveils Program To Promote HealthTech Startups
September 12, 2024
Battery Startup Announces Superfast Charging For Electric Vehicles
September 12, 2024
Automated Marketing Firm Unveils New Image Editing Suite
September 11, 2024
Israeli Renewable Energy Firm Launches First US Solar Power Project
September 11, 2024
Facebook comments